LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 3.07X leverage
Performance
- Low
- ₹520
- High
- ₹535
- 52 Week Low
- ₹440
- 52 Week High
- ₹710
- Open Price₹535
- Previous Close₹535
- Volume22,608
- 50 DMA₹484.26
- 100 DMA₹501.09
- 200 DMA₹531.52
Investment Returns
- Over 1 Month + 8.64%
- Over 3 Month + 1.29%
- Over 6 Month -5.96%
- Over 1 Year -25.69%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.2
- PEG Ratio
- -0.8
- Market Cap Cr
- 1,059
- P/B Ratio
- 1.5
- Average True Range
- 19.18
- EPS
- 39.94
- Dividend Yield
- 0.3
- MACD Signal
- -1.98
- RSI
- 68.13
- MFI
- 69.9
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹528.85
-6.3
(-1.18%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹480.05
- 50 Day
- ₹484.26
- 100 Day
- ₹501.09
- 200 Day
- ₹531.52
Resistance and Support
528.02
- R3 551.23
- R2 543.22
- R1 536.03
- S1 520.83
- S2 512.82
- S3 505.63
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹528 As on 12 February, 2026 | 02:39
The Market Cap of Lincoln Pharmaceuticals is ₹1059.3 Cr As on 12 February, 2026 | 02:39
The P/E ratio of Lincoln Pharmaceuticals is 13.2 As on 12 February, 2026 | 02:39
The PB ratio of Lincoln Pharmaceuticals is 1.5 As on 12 February, 2026 | 02:39
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.